Informa
2025年9月15-18日
米国、マサチューセッツ州ボストン、Hynes Convention Center
Key Sessions
Niklas Engler
PLENARY KEYNOTE: CMC Development - A Key Differentiator for Biotech
F. Hoffmann-La Roche
James Warren, Ph.D.
PLENARY KEYNOTE: Strategic Considerations for the BLA-Enabling CMC Development of AAV Gene Therapy Programs
Ultragenyx Pharmaceutical Inc.
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL